Can we introduce evidence based prescribing of complementary drug therapies into primary care? A randomised controlled trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN19338940

Enrollment

Registered

2005-12-20

Start date

2004-06-26

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis Musculoskeletal Diseases Gonarthrosis

Interventions

Dissemination of a recommendation for the prescribing of glucosamine for knee osteoarthritis endosed by the Bury PCT Medicines Management Subgroup and accompanied by a letter of support signed by the

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: General practitioners in Bury PCT

Exclusion criteria

Exclusion criteria: General practitioners on the local medicines management subgroup and the other GPs in their practices

Design outcomes

Primary

Measure	Time frame
Change in the mean number of prescriptions for glucosamine sulphate 500 mg per general practitioner over study period.	—

Secondary

Measure	Time frame
1. Change in cost to the NHS of prescriptions for glucosamine per general practitioner over study period 2. Proportion of GP prescribing glucosamine sulphate 500 mg during study period 3. If sufficient change in prescribing observed, number of admissions for gastrointestinal bleeding 4. Change in mean number of prescriptions of NSAID and COX2	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026